Immuno-Oncology is a rapidly growing therapeutic field that embraces the concept of modulating the immune system to recognize tumor cells and target them for destruction—by either harnessing the efforts of the immune system or preventing the evasion of tumor cells from therapeutic targeting. Charles River's platform can advance biologics and small-molecule modulators to the clinic.